APA (7th ed.) Citation

A, K., D, G., MW, M., U, L., M, S., A, K., . . . S, C. (2024). A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants. Naunyn-Schmiedeberg's archives of pharmacology, 397(12), 9823. https://doi.org/10.1007/s00210-024-03245-x

Chicago Style (17th ed.) Citation

A, Kuemmerle, et al. "A Randomized, Open-label Two-period Crossover Pilot Study to Evaluate the Relative Bioavailability in the Fed State of Atovaquone-proguanil (Atoguanil™) Versus Atovaquone-proguanil Hydrochloride (Malarone®) in Healthy Adult Participants." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 12 (2024): 9823. https://doi.org/10.1007/s00210-024-03245-x.

MLA (9th ed.) Citation

A, Kuemmerle, et al. "A Randomized, Open-label Two-period Crossover Pilot Study to Evaluate the Relative Bioavailability in the Fed State of Atovaquone-proguanil (Atoguanil™) Versus Atovaquone-proguanil Hydrochloride (Malarone®) in Healthy Adult Participants." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 12, 2024, p. 9823, https://doi.org/10.1007/s00210-024-03245-x.